Stereotaxis
STXS • AMEX
Stereotaxis is a medical - instruments & supplies company in the healthcare sector trading on AMEX, led by CEO David Leo Fischel, with a market cap of $177.0M.
CEODavid Leo Fischel
Next Earnings
Upcoming earnings announcement for Stereotaxis
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.05
Revenue Estimate
$8.9M
Earnings History
Past 12 earnings reports for Stereotaxis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Q4 2025 | -$0.06Est: -$0.06 | 0.0% | $8.6MEst: $9.2M | -6.1% | — |
| Nov 11, 2025 | Q3 2025 | -$0.07Est: -$0.06 | -16.7% | $7.5MEst: $8.6M | -13.5% |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.05Est: -$0.07 | +28.6% | $8.8MEst: $8.1M | +9.2% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.07Est: -$0.07 | 0.0% | $7.5MEst: $6.9M | +8.6% | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.09Est: -$0.06 | -50.0% | $6.3MEst: $6.4M | -1.2% | 10-K |
| Nov 11, 2024 | Q3 2024 | -$0.08Est: -$0.05 | -60.0% | $9.2MEst: $7.1M | +29.5% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.07Est: -$0.05 | -40.0% | $4.5MEst: $5.6M | -19.9% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.06Est: -$0.06 | 0.0% | $6.9MEst: $7.0M | -1.7% | 10-Q |
| Mar 4, 2024 | Q4 2023 | -$0.07Est: -$0.07 | 0.0% | $4.6MEst: $7.7M | -40.7% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.07Est: -$0.06 | -16.7% | $7.8MEst: $8.3M | -5.8% | — |
| Aug 10, 2023 | Q2 2023 | -$0.07Est: -$0.07 | 0.0% | $7.9MEst: $6.7M | +17.6% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.07Est: -$0.06 | -16.7% | $6.5MEst: $6.6M | -1.1% | 10-Q |